MYCOBACTERIUM - ANVISA Registration 80954880204
Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80954880204 and manufactured by Eco Diagnostica Ltda. The registration is held by Eco Diagnostica Ltda with validity until Jun 26, 2033.
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80954880204
25351156085202325
14633154000206
Company Information
Dates and Status
Jun 26, 2023
26/06/2033
09/18/2025 19:00:01
MYCOBACTERIUM
Família AutoLumo TB-IGRA Micropartículas (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513450
Jun 16, 2025
MYCOBACTERIUM
Família AutoLumo TB-IGRA Micropartículas (CLIA)
Not specified
80102513450
Jun 16, 2025
MYCOBACTERIUM
TESTE RÁPIDO ONSITE TB IgG/IgM Combo
Not specified
80524900050
Nov 28, 2016
MYCOBACTERIUM
TESTE RÁPIDO ONSITE TB IgG/IgM Combo
CTK BIOTECH, INC.
80524900050
Nov 28, 2016
MYCOBACTERIUM
Família ichroma™ IGRA-TB
Not specified
10350840461
Aug 05, 2024
MYCOBACTERIUM
RIDA® TB Tubes
R-BIOPHARM AG
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA® TB Tubes
Not specified
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA®QUICK TB
Not specified
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDA®QUICK TB
R-BIOPHARM AG
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDASCREEN® TB
R-BIOPHARM AG
82890930012
Jun 23, 2025